Contract Specifications
See MoreContract
N/A
Contract Size
N/A
Tick Size
N/A
Trading Hours
N/A
Exchange
ICE/EU
Point Value
N/A
ICE ECX CER Dec '12 (CQZ12)
0.34s +0.03 (+9.68%) 12/17/12 [ICE/EU]
N/A x N/A N/A x N/A
for Mon, Dec 17th, 2012
Day Low
0.27
Day High
0.42
Open 0.42
Previous Close 0.31 0.31
Volume 4,012 4,012
Open Interest 49,485 49,485
Stochastic %K 21.48% 21.48%
Weighted Alpha -88.78 -88.78
5-Day Change -0.27 (-44.26%) -0.27 (-44.26%)
52-Week Range 0.27 - 6.18 0.27 - 6.18
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
-
OHLC Bars
-
Colored OHLC Bars
-
HLC Bars
-
Candlestick Hollow
-
Candlestick Open-to-Close
-
Candlestick Close-to-Close
-
Heikin-Ashi
-
Line Chart
-
Area Chart
-
Renko
-
Column
-
Baseline
-
Line Break
-
Range
-
Kagi
-
Point And Figure
Get Realtime - Quotes and Charts for Futures Traders. Learn More >>
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.
Most Recent Stories
More News
Oil Rebounds CLM = 61.83s +1.08 (+1.78%) QAM = 65.85s +1.18 (+1.82%)
May WTI crude oil (CLK25 ) Wednesday closed up +1.17 (+1.86%), and May RBOB gasoline (RBK25 ) closed up +0.0190 (+0.94%). Crude oil and gasoline prices on Wednesday rallied moderately. Wednesday's slide...
May Nymex natural gas (NGK25 ) on Wednesday closed down by -0.082 (-2.46%). May nat-gas prices on Wednesday tumbled to a 2-1/2 month low and settled moderately lower. The outlook for warm spring US temperatures...
May WTI crude oil (CLK25 ) today is up +1.27 (+2.07%), and May RBOB gasoline (RBK25 ) is up +0.0139 (+0.69%). Crude oil and gasoline prices today are moderately higher. Today's slide in the dollar is...
WTI Crude Oil Futures (May) Yesterday’s Settlement: 61.33, down -0.20 [-0.33%] WTI Crude Oil futures finished the day lower, driven by Dollar strength, fundamental selling, and reportedly positive progress...
May WTI crude oil (CLK25 ) Tuesday closed down -0.20 (-0.33%), and May RBOB gasoline (RBK25 ) closed up +0.0022 (+0.11%). Crude oil and gasoline prices on Tuesday settled mixed. Tuesday's stronger dollar...
May Nymex natural gas (NGK25 ) on Tuesday closed up by +0.004 (+0.12%). May nat-gas prices on Tuesday recovered from a 2-1/4 month low and settled slightly higher. Short covering emerged in nat-gas futures...
The energy sector of the commodities market moved higher in Q1 2025, led by double-digit percentage gains in gasoline and natural gas. The energy composite gained 4.62% over the first three months of 2025....
Boeing is back in the spotlight, this time not because of security issues, but because of geopolitics, ongoing trade wars, falling oil prices, and growing fears of a global economic slowdown.
May WTI crude oil (CLK25 ) today is down -0.23 (-0.37%), and May RBOB gasoline (RBK25 ) is up +0.0033 (+0.16%). Crude oil and gasoline prices today are mixed. Today’s stronger dollar is weighing on crude...
Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2023
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2022
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Hosts Third Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Announces Board Change
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & Exposition
/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...
Poseida Therapeutics to Present Early Data from Phase 1 Trials of P-MUC1C-ALLO1 and P-BCMA-ALLO1 at ESMO Immuno-Oncology 2022 Annual Congress
P-MUC1C-ALLO1 and P-BCMA-ALLO1 were well tolerated, with no dose-limiting toxicities (DLTs), cytokine release syndrome (CRS), graft vs host disease (GVHD) or...
